Genomics

KromaTiD Launches Pinpoint FISH™ DNA Probes

KromaTiD

KromaTiD a single-cell analysis company focused on the research, development, and commercialization of technology solutions for the cell and gene therapy market, announces the launch of KromaTiD Pinpoint FISH™ Probes.

This product offering expands on our 10 years of service providing high-resolution assays with superior detection, and robust data, for our client’s large pharmaceutical projects. We are now offering to our customers, KromaTiD Pinpoint FISH™ probes in a commercial catalog.

Our VP of Research and Development Erin Cross says that
The launch of our catalog of Pinpoint FISH™ Probes is the culmination of KromaTiD’s years of being at the forefront of genomics research, and our catalog of products stands out from our competitors, by having a greater resolution and signal strength, lower background, and extremely robust chromosome enumeration detection for a leading economical price.”

KromaTiD’s Pinpoint FISH™ probes are designed to easily detect biomarkers, and quantify chromosomal rearrangements, structural variants, and mutations in targets of interest, providing researchers with better sensitivity than BAC FISH Probes.

KromaTiD’s whole chromosome paint probes, as well as Pinpoint FISH™ probes targeting sub-telomeres and centromeres, can be labeled with any of our five fluor probe color options. Custom probes and labeling are available upon request.

For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to AI-Techpark.com.

PR Newswire

PR Newswire empowers communicators to identify and engage with key influencers, craft and distribute meaningful stories, and measure the financial impact of their efforts. Cision is a leading global provider of earned media software and services to public relations and marketing communications professionals.

Related posts

Neuvivo Announces Addition of Michael Snyder, PhD

PR Newswire

Phase Genomics Advances Precision Oncology with OncoTerra™

Business Wire

Almaden Genomics Announces Launch of g.nome™ Platform

PR Newswire